Search research articles
Contact Us
Filters
Showing results (41-50 of 47) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 47 results.
Neurogastroenterology and Motility
|
February 18, 2011
The role of small intestinal bacterial overgrowth in postgastrectomy patients
C N Paik, M-G Choi, C H Lim, et al.
Alimentary Pharmacology & Therapeutics
|
June 6, 2018
Incidence of psoriasiform diseases secondary to tumour necrosis factor antagonists in patients with inflammatory bowel disease: a nationwide population-based cohort study
J M Bae, H H Lee, B-I Lee, et al.
Digestive Diseases and Sciences
|
February 22, 2002
Effect of rebamipide in treatment of Helicobacter pylori-associated duodenal ulcer: attenuation of chemokine expression and nitrosative damage
K W Choi, Y C Lee, I S Chung, et al.
Neurogastroenterology and Motility
|
March 27, 2015
Efficacy of combination therapy with probiotics and mosapride in patients with IBS without diarrhea: a randomized, double-blind, placebo-controlled, multicenter, phase II trial
C H Choi, J G Kwon, S K Kim, et al.
Endoscopy
|
December 12, 2007
Can we predict spontaneous capsule passage after retention? A nationwide study to evaluate the incidence and clinical outcomes of capsule retention
J H Cheon, Y-S Kim, I-S Lee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 5, 2020
A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial<sup>☆</sup>
S H Park, D H Lim, T S Sohn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 7, 2018
Impact of genomic alterations on lapatinib treatment outcome and cell-free genomic landscape during HER2 therapy in HER2+ gastric cancer patients
S T Kim, K C Banks, E Pectasides, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 47) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 47 results.
Neurogastroenterology and Motility
|
February 18, 2011
The role of small intestinal bacterial overgrowth in postgastrectomy patients
C N Paik, M-G Choi, C H Lim, et al.
Alimentary Pharmacology & Therapeutics
|
June 6, 2018
Incidence of psoriasiform diseases secondary to tumour necrosis factor antagonists in patients with inflammatory bowel disease: a nationwide population-based cohort study
J M Bae, H H Lee, B-I Lee, et al.
Digestive Diseases and Sciences
|
February 22, 2002
Effect of rebamipide in treatment of Helicobacter pylori-associated duodenal ulcer: attenuation of chemokine expression and nitrosative damage
K W Choi, Y C Lee, I S Chung, et al.
Neurogastroenterology and Motility
|
March 27, 2015
Efficacy of combination therapy with probiotics and mosapride in patients with IBS without diarrhea: a randomized, double-blind, placebo-controlled, multicenter, phase II trial
C H Choi, J G Kwon, S K Kim, et al.
Endoscopy
|
December 12, 2007
Can we predict spontaneous capsule passage after retention? A nationwide study to evaluate the incidence and clinical outcomes of capsule retention
J H Cheon, Y-S Kim, I-S Lee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 5, 2020
A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial<sup>☆</sup>
S H Park, D H Lim, T S Sohn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 7, 2018
Impact of genomic alterations on lapatinib treatment outcome and cell-free genomic landscape during HER2 therapy in HER2+ gastric cancer patients
S T Kim, K C Banks, E Pectasides, et al.
Page
of 5